why choose us

First received: September 15, 2023

Clinical Trial: A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Colitis, Ulcerative

Study Type: INTERVENTIONAL


Official Title: A Phase 2b Multicenter, Randomized, Placebo- Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Moderately to Severely Active Ulcerative Colitis

Brief Summary: The purpose of this study is to evaluate the safety and effectiveness of JNJ-77242113 compared with placebo in participants with moderately to severely active ulcerative colitis.

Read more